Group B streptococcal disease: a life-threatening infection in the newborn.
Group B streptococcal (GBS) disease, a life-threatening infection in newborns in the United States, causes considerable neonatal morbidity and mortality. GBS is also a major source of maternal infection. Screening during pregnancy leads to early identification. Intrapartal treatment of affected mothers can prevent harmful neonatal effects. Implementation of screening and treatment protocols is recommended for the protection of all obstetric and neonatal patients.
Gallagher
R J
RJ
Fuller
C A
CA
D002985:Clinical Protocols; D003663:Decision Trees; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening; D009722:Nurse Practitioners; D011247:Pregnancy; D012307:Risk Factors; D013290:Streptococcal Infections / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D013292:Streptococcus agalactiae; D014481:United States / Q000453:epidemiology